The Role of Prediction Models: Best practices in Identifying Cirrhosis and HCC in Patients Infected with HBV

Volume 3, Issue 4.

Dr. Anna Suk-Fong Lok, MD, FRCP, Professor in the Department of Internal Medicine and Director of Clinical Hepatology in the Division of Gastroenterology at the University of Michigan Health System discusses predictive models for cirrhosis in the form of case-study scenarios for the clinical practice.

New Therapies in Cystic Fibrosis Directed Toward the Basic Defect

Volume 4, Issue 8.

In this podcast guest author Steven Rowe, MD, Associate Professor of Medicine from the University of Alabama at Birmingham, describes how CFTR modulator therapy fits into the clinical armamentarium of CF lung disease; identifies which patients are most appropriate for CF modulator treatment; and describes current research efforts and how to identify patients suitable for referral for consideration in CFTR modulator clinical trials.